Protect Your Heart

Anastasia Fahlman and Sarah Damiani from the University of Ottawa speak with Dr. Erin Mulvihill, Scientist and Director of the Energy Substrate Metabolism Research Laboratory at the University of Ottawa Heart Institute. Tune in to learn more about her recent work published in CellPress, which explores the potential mechanisms underlying the cardioprotective benefits of metabolic surgery and GLP-1RA-based therapies. It also discusses recent evidence and emerging therapies in this dynamic area of research.

Learn more: https://www.sciencedirect.com/science/article/pii/S1043276024001930                                                                     

Credits for music: Soundtracks by the Underground Drive. All rights reserved. Listen more:

https://music.apple.com/ca/artist/the-underground-drive/1571062779

https://open.spotify.com/artist/4sCJG8TMQyTZ9FDd1JjJmR

Podcast by Sarah Damiani (Voice, Producer, Show Co-Host, Writer Editor, Audio Master) and Anastasia Fahlman (Voice, Show Co-Host, Writer Editor, Audio Master)

Chapters

• 0:07 Introduction
• 0:52 Overview of Dr. Mulvihill’s Research
• 1:40 Ethical and Medical Concerns of using GLP1-RAs for Non-Medical Reasons
• 3:10 How GLP1-RAs has changed the treatment of Type 2 Diabetes
• 4:43 Long term impacts of GLP1-RA therapy
• 6:12 Future topics of research to better patient outcomes and quality of life
• 7:23 Synthesis of information for scientific community for new hypothesis
• 9:00 The gap in knowledge for women in GLP1-RA therapy research
• 10:20 Patient experiences with GLP1-RA therapies
• 12:21 Conclusion and thanks